Filters: keyword is Body Temperature [Clear All Filters]
- 2007
Allometric scaling of pharmacodynamic responses: application to 5-Ht1A receptor mediated responses from rat to man,
Pharm Res, vol. 24, no. 11, pp. 2031-9.
- 2004
Mechanism-based pharmacokinetic-pharmacodynamic modeling of 5-HT1A receptor agonists: estimation of in vivo affinity and intrinsic efficacy on body temperature in rats,
J Pharmacol Exp Ther, vol. 308, no. 3, pp. 1012-20.
- 2002
Pharmacokinetic-pharmacodynamic modelling of the hypothermic and corticosterone effects of the 5-HT1A receptor agonist flesinoxan,
Eur J Pharmacol, vol. 445, no. 1-2, pp. 43-54.
A competitive interaction model predicts the effect of WAY-100,635 on the time course of R-(+)-8-hydroxy-2-(di-n-propylamino)tetralin-induced hypothermia,
J Pharmacol Exp Ther, vol. 300, no. 1, pp. 330-8.
Population pharmacokinetic and pharmacodynamic modeling of propofol for long-term sedation in critically ill patients: a comparison between propofol 6% and propofol 1%,
Clin Pharmacol Ther, vol. 72, no. 6, pp. 670-84.
Pharmacokinetic-pharmacodynamic modeling of buspirone and its metabolite 1-(2-pyrimidinyl)-piperazine in rats,
J Pharmacol Exp Ther, vol. 303, no. 3, pp. 1130-7.
- 2001
A set-point model with oscillatory behavior predicts the time course of 8-OH-DPAT-induced hypothermia,
Am J Physiol Regul Integr Comp Physiol, vol. 281, no. 6, pp. R2059-71.
- 2000
Enantioselective high-performance liquid chromatographic analysis of the 5-HT1A receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin. Application to a pharmacokinetic-pharmacodynamic study in rats,
J Chromatogr B Biomed Sci Appl, vol. 738, no. 1, pp. 67-73.
- 1997
Pharmacokinetic-pharmacodynamic modelling of the EEG effect of alfentanil in rats,
J Pharmacol Toxicol Methods, vol. 38, no. 2, pp. 99-108.
- 1986
Progesterone in saliva: pitfalls and consequent implications for accuracy of the determination,
Clin Chem, vol. 32, no. 5, pp. 831-4.
